{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:28Z","timestamp":1791920068268,"version":"4.3.4"},"reference-count":72,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0\/uk\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.2217\/fmb.11.44","type":"journal-article","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T02:51:32Z","timestamp":1309229492000},"page":"677-691","source":"Crossref","is-referenced-by-count":123,"title":["Development of Novel Drugs for Human African Trypanosomiasis"],"prefix":"10.1080","volume":"6","author":[{"given":"Reto","family":"Brun","sequence":"first","affiliation":[{"name":"Department Medical Parasitology & Infection Biology,Swiss Tropical & Public Health Institute, and,University of Basel,\r          CH-4002 Basel,\r          Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Don","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative,\r          Geneva,\r          Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Chemistry,SCYNEXIS, Inc.,\r          PO Box 12878,\r          Research Triangle Park,\r          NC,\r          27709-2878,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Zhuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Eshelman School of Pharmacy,University of North Carolina,\r          Chapel Hill,\r          NC,\r          USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Barrett","sequence":"additional","affiliation":[{"name":"Wellcome Trust Centre for Molecular Parasitology,University of Glasgow,\r          Glasgow,\r          Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,6,27]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60829-1"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33945"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707354"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000303"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2010.07156.x"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1007074107"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2009.01383.x"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-1-3"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1602.090967"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61117-X"},{"key":"e_1_3_3_13_1","first-page":"CD006201","article-title":"Chemotherapy for second-stage Human African trypanosomiasis.","volume":"4","author":"Lutje V","year":"2010","unstructured":"Lutje V , SeixasJ, KennedyA: Chemotherapy for second-stage Human African trypanosomiasis.Cochrane Database Syst. Rev.4 , CD006201 (2010).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_3_14_1","first-page":"876","article-title":"Diamidines for human African trypanosomiasis.","volume":"11","author":"Paine MF","year":"2010","unstructured":"Paine MF , WangMZ, GenerauxCNet al. : Diamidines for human African trypanosomiasis.Curr. Op. Investig. Drugs.11 , 876\u2013883 (2010).","journal-title":"Curr. Op. Investig. Drugs."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.031351"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001204"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2010.11.010"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2010.09.002"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05706.x"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711014105"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.230847"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00332-10"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00926669"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000923"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.013391"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00225-09"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00831-08"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00192-06"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.024653"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.010587"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.016428"},{"key":"e_1_3_3_32_1","unstructured":"Generaux CN : Effects of parasitic infection on the pharmacokinetics and disposition of pentamidine analogs. PhD Thesis University of North Carolina at Chapel Hill NC USA (2010)."},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.024083"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.149872"},{"key":"e_1_3_3_35_1","first-page":"129","article-title":"Organ specific accumulation and distribution of structurally related anti-trypanosomal compounds: a possible role in renal toxicity.","volume":"81","author":"Goldsmith RB","year":"2009","unstructured":"Goldsmith RB , TidwellRR: Organ specific accumulation and distribution of structurally related anti-trypanosomal compounds: a possible role in renal toxicity.Am. J. Trop. Med. Hyg.81 , 129 (2009).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/ml100013s"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00498-10"},{"key":"e_1_3_3_38_1","first-page":"11","article-title":"SCYX-7158, an orally active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.","author":"Jacobs RT","year":"2011","unstructured":"Jacobs RT , NareB, WringSAet al. : SCYX-7158, an orally active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.PLoS Negl. Trop. Dis.11 (2011) (In press).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32833f9fd0"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2007.08.019"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2684"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.03.045"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050237b"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000659"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm1004754"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200900262"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.045336"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.06.070"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2009.01.058"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(06)63002-9"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.081588"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01674-08"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20071185"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00047-09"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R500016-JLR200"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2009.09.006"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08893"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805820105"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00364-08"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2010.04.001"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2008.06131.x"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2010.07236.x"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20081787"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.074591"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6818com"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328315cca9"},{"key":"e_1_3_3_67_1","first-page":"297","article-title":"Systems approaches to polypharmacology and drug discovery.","volume":"13","author":"Boran AD","year":"2010","unstructured":"Boran AD , IyengarR: Systems approaches to polypharmacology and drug discovery.Curr. Opin. Drug Discov. Devel.13 , 297\u2013309 (2010).","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2006.00389.x"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2010.07.038"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000609"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050055"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182009006416"},{"key":"e_1_3_4_2_1","unstructured":"WHO: African trypanosomiasis (sleeping sickness). Fact sheet No. 259. October 2010 www.who.int\/mediacentre\/factsheets\/fs259\/en\/"},{"key":"e_1_3_4_3_1","unstructured":"Pan African Tsetse and Trypanosomiasis Eradication Campaign (PATTEC) www.africa-union.org\/Structure_of_the_Commission\/depPattec.htm"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb.11.44","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:40:31Z","timestamp":1719124831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb.11.44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.2217\/fmb.11.44"],"URL":"https:\/\/doi.org\/10.2217\/fmb.11.44","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}